COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 181

Article download: 97

Indian Journal of Microbiology Research


Prevalence of multi-drug resistant (MDR) pulmonary tuberculosis in a tertiary care rural hospital in Western Maharashtra, India


Full Text PDF Share on Facebook Share on Twitter


Author Details : Snehal Patil, Prasanna Nakate*, Suvarna Patil, Yogendra Shelke

Volume : 6, Issue : 3, Year : 2019

Article Page : 237-240


Suggest article by email


Abstract

Introduction: The emergence of Multi-Drug Resistant tuberculosis (MDR-TB) has become a big issue in
tuberculosis (TB) control programs in recent times. It is seen more frequently in patients already treated
for TB, but has been now diagnosed in new TB patients as a primary infection. Present study was carried
out to find out the prevalence of MDR-TB in new and previously treated pulmonary TB patients attending
a tertiary care rural hospital.
Material and Methods: The study included a total of 1154 suspected MDR-TB patients out of which 1052
were new patients while 102 had received anti-TB drugs in past. Sputum samples of these patients were
tested using GeneXpert MTB/RIF assay to detect Mycobacterium tuberculosis infection and Rifampicin
resistance.
Results: MDR-TB was detected in 5.55% of overall patients. In case of new TB suspects, MDR-TB was
detected in 4.37%, while 17.65% of patients with past history of anti-TB treatment had MDR-TB.
Conclusion: Improper management of drug sensitive TB has led to emergence of MDR-TB. Previous drug
treatment seems to be the most important risk factor for acquiring resistance. It is important to strongly
suspect and correctly diagnose MDR-TB at an early stage in all suspected patients of tuberculosis to control
the spread of this disease and for improving the management of all TB cases.

Keywords: Multidrug resistant tuberculosis (MDRTB), GeneXpert assay, Rifampicin resistance, M tuberculosis.

Doi : 10.18231/j.ijmr.2019.052

How to cite : Patil S, Nakate P, Patil S, Shelke Y, Prevalence of multi-drug resistant (MDR) pulmonary tuberculosis in a tertiary care rural hospital in Western Maharashtra, India. Indian J Microbiol Res 2019;6(3):237-240

Copyright © 2019 by author(s) and Indian J Microbiol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)